envafolimab: Clinical Trials

9 trials of envafolimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 1 active not recruiting, 1 unknown. 9 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 4, Recruiting 3, Active not recruiting 1, Unknown 1
Phase 23Recruiting 2, Unknown 1

Follow envafolimab: new trials by email Literature Review of envafolimab trials Research Report on envafolimab

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
KGX101 injection, Envafolimab - Advanced or Metastatic Solid Tumors
Phase 1RecruitingKangabio AUSTRALIA LTD PTY572024-11-272026-04-24
RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
RC48, Envafolimab - Prostate Cancer, CDK12 Gene Mutation
Phase 1 / Phase 2RecruitingTianjin Medical University Second Hospital722024-09-242024-10-29
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.
KGX101- Cohort -1, KGX101- Cohort 1, KGX101- Cohort 2 - Advanced or Metastatic Solid Tumors
Phase 1Active not recruitingKangabio AUSTRALIA LTD PTY542023-12-132026-04-29
Phase I Trial of Envafolimab for Healthy Male Subjects
Envafolimab with new manufacturing process, Envafolimab with old manufacturing process - Healthy Male
Phase 1Completed3D Medicines (Sichuan) Co., Ltd.1602023-05-292024-08-14
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
YH001, Envafolimab, Doxorubicin - Advanced Sarcoma, Metastatic Sarcoma
Phase 1 / Phase 2UnknownTracon Pharmaceuticals Inc.152022-11-142023-09-21
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Lenvatinib + Envafolimab, Sunitinib - Solid Tumors, Non-small Cell Lung Cancer
Phase 1 / Phase 2Recruiting3D Medicines (Sichuan) Co., Ltd.1702021-11-152026-03-25
A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
KN035 - Advanced or Metastatic Solid Tumors
Phase 1Completed3D Medicines (Sichuan) Co., Ltd.352017-09-152022-02-08
Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors
KN035 - Solid Tumors
Phase 1Completed3D Medicines (Sichuan) Co., Ltd.2872017-03-212022-03-03
Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
KN035 - Solid Tumors
Phase 1Completed3D Medicines (Sichuan) Co., Ltd.282017-01-132021-06-02

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Chondrosarcoma (1)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  Prostatic Neoplasms (1)  ·  Sarcoma (1)

Sponsors

3D Medicines (Sichuan) Co., Ltd. (5)  ·  Kangabio AUSTRALIA LTD PTY (2)  ·  Tianjin Medical University Second Hospital (1)  ·  Tracon Pharmaceuticals Inc. (1)

Countries

China (5)  ·  United States (2)  ·  Australia (1)  ·  Japan (1)

Top investigators

David Liu, M.D. (1)  ·  James Freddo, MD (1)  ·  Jun Guo (1)  ·  Qing He (1)  ·  Tianshu Liu (1)  ·  Weidong Jiang, Dr (1)

Results publications

PMID 38982653, PMID 33973293, PMID 35932387